Status:
TERMINATED
Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Children's Hospital Colorado
Conditions:
Burns
Skin Graft Complications
Eligibility:
All Genders
31-80 years
Phase:
NA
Brief Summary
The investigators aim to study whether Suprathel, a synthetic temporary skin substitute developed by PolyMedics Innovations GmBH aids in the management of patient pain and wound healing when compared ...
Detailed Description
Acute burn and donor site dressing changes are among the most traumatic and painful procedures performed on awake children and adults (7, 8). As a result, it is important to utilize dressings that: 1)...
Eligibility Criteria
Inclusion
- Children 31 days old -17 years old
- Have a burn injury or open wound of any percentage TBSA
- Require a skin graft
Exclusion
- allergy to one of the dressings involved in the study,
- burn in close proximity to the donor site,
- the donor site has been harvested in a previous surgery,
- prisoners,
- children under the protection of the department of human services,
- pregnant women,
- those with impaired decision-making capacity.
Key Trial Info
Start Date :
July 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 23 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04014400
Start Date
July 7 2019
End Date
July 23 2020
Last Update
October 22 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045
2
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045